PATENT CLAIM ANALYSIS

Application Number: 15893546
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "465000"]

Abstract:
In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.

Claim (Index 3):
The method of  claim 2 , wherein the capsule is a soft gelatin capsule.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.21622
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15893542', '15372385', '15893550', '14521230', '14624051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8236607224560059
- 35 USC 102 Novelty (BERT): 0.6331406274442354
- Combined Prediction Score: 0.8046087129548288
- Mean Citation Score: 552.7723100000002
- Max Citation Score: 690.2291
- Similarity Product: 537.5112232125581

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test